Kolkata-based healthcare startup iKure to get funds from Ratan Tata

Published On 2020-11-12 06:15 GMT   |   Update On 2021-11-22 17:29 GMT
Advertisement

New Delhi: Healthcare services startup, iKure on Tuesday said veteran industrialist Ratan Tata has invested in the company an undisclosed sum.

The company, which delivers primary healthcare services through a network of clinics, digital technologies and trained frontline health workers, said it plans to rapidly scale-up operations across India and globally with fresh funds coming in.

Commenting on the investment by Tata in the company, iKure Founder and CEO Sujay Santra said: "We are extremely pleased to have been considered by Ratan Tata for an investment. This is a huge honour and encouragement for us."

Till date, iKure has provided primary healthcare services to over 1.1 million people across seven states in India and is looking to provide healthcare services to over 10 million people within the next 5 years, the company said.

iKure has been focusing on delivering primary healthcare by addressing several challenges like accessibility, affordability, availability and awareness. iKure''s technology platform is currently being used in several African countries.

Tata is known to invest in start-ups and has made several investments in many tech-driven companies in his personal capacity after retiring as chairman of Tata Sons in December 2012.


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News